tbuckley/cabot-search huggingface dataset:
Sputum colour as a simplified effective biomarker for clinical assessment of bronchiectasis
Authors: Rui-di Tang, Jun-qing Yue, Wei-jie Guan
Journal: European Respiratory Journal (2024)

Bronchiectasis is a structural lung disease characterised by chronic airway inflammation due to various aetiologies, with a vicious circle of recurrent infections, chronic inflammation, impaired mucociliary clearance and structural damage that collectively result in clinical progression [1]. The most prominent clinical manifestations of bronchiectasis are chronic cough and mucopurulent sputum production, the consequence of airway mucus hypersecretion and heightened inflammatory responses which could predispose to irreversible airway destruction [2, 3]. Amid this vicious circle of bronchiectasis pathogenesis is chronic inflammation characterised by predominantly neutrophilic inflammation. In light of a paucity of validated direct laboratory testing methods for assessing neutrophilic inflammation in routine clinical practice, researchers have developed a novel lateral flow device to evaluate the neutrophil elastase activity from sputum in bronchiectasis (NEATstik), whose grading correlated significantly with the risks of airway infection and future exacerbations [4]. Nevertheless, enormous challenges remain, especially in the resource-constrained areas where supply of such tools falls short. The exploration of a simpler, patient-friendly bedside assessment tool would therefore open up new avenues for the management of bronchiectasis, particularly in the community setting and in many developing countries. Sputum colour is a simple and effective biomarker for assessing severity and prognosis of bronchiectasis <https://bit.ly/49cXEVz>
“Efficacy and safety of ralinepag, a novel oral IP agonist, in PAH patients on mono or dual background therapy: results from a phase 2 randomised, parallel group, placebo-controlled trial.” F. Torres, H. Farber, A. Ristic,<i>et al</i>.<i>Eur Respir J</i>2019; 54: 1901030.
Journal: European Respiratory Journal (2024)
25-Hydroxycholesterol regulates lysosome AMP kinase activation and metabolic reprogramming to educate immunosuppressive macrophages
Authors: Jun Xiao, Shuang Wang, Longlong Chen, Xinyu Ding, Yuanhao Dang, Mingshun Han, Yuxiao Zheng, Huan Shen, Sifan Wu, Mingchang Wang, Dan Yang, Na Li, Chen Dong, Miao Hu, Chen Su, Weiyun Li, Lijian Hui, Youqiong Ye, Huiru Tang, Bin Wei, Hongyan Wang
Journal: Immunity (2024)
Pembrolizumab Plus Chemotherapy for Metastatic NSCLC With Programmed Cell Death Ligand 1 Tumor Proportion Score Less Than 1%: Pooled Analysis of Outcomes After Five Years of Follow-Up
Authors: Shirish M. Gadgeel, Delvys Rodríguez-Abreu, Balazs Halmos, Marina C. Garassino, Takayasu Kurata, Ying Cheng, Erin Jensen, Mark Shamoun, Kumar Rajagopalan, Luis Paz-Ares
Journal: Journal of Thoracic Oncology (2024)
Trehalose enhanced cold atmospheric plasma-mediated cancer treatment
Authors: Xiaona Cao, Tianxu Fang, Mo Chen, Tianqin Ning, Jianyu Li, Peter M. Siegel, Morag Park, Zhitong Chen, Guojun Chen
Journal: Biomaterials (2024)

Cold atmospheric plasma (CAP) is a unique form of physical plasma that has shown great potential for cancer therapy. CAP uses ionized gas to induce lethal oxidative stress on cancer cells; however, the efficacy of CAP therapy continues to be improved. Here, we report an injectable hydrogel-mediated approach to enhance the anti-tumor efficacy of CAP by regulating the phosphorylation of eIF2α. We discovered that reactive oxygen and nitrogen species (ROS/RNS), two main anti-tumor components in CAP, can lead to lethal oxidative stress on tumor cells. Elevated oxidative stress subsequently induces eIF2α phosphorylation, a pathognomonic marker of immunogenic cell death (ICD). Trehalose, a natural disaccharide sugar, can further enhance CAP-induced ICD by elevating the phosphorylation of eIF2α. Moreover, injectable hydrogel-mediated delivery of CAP/trehalose treatment promoted dendritic cell (DC) maturation, initiating tumor-specific T-cell mediated anti-tumor immune responses. The combination therapy also supported the polarization of tumor-associated macrophages to an M1-like phenotype, reversing the immunosuppressive tumor microenvironment and promoting tumor antigen presentation to T cells. In combination with immune checkpoint inhibitors (i.e., anti-programmed cell death protein 1 antibody, aPD1), CAP/trehalose therapy further inhibited tumor growth. Importantly, our findings also indicated that this hydrogel-mediated local combination therapy engaged the host systemic innate and adaptive immune systems to impair the growth of distant tumors.
Author correction to “Identification of the dietary supplement capsaicin as an inhibitor of Lassa virus entry” [Acta Pharmaceutica Sinica B 10 (2020) 789–798]
Authors: Ke Tang, Xiaoyu Zhang, Ying Guo
Journal: Acta Pharmaceutica Sinica B (2024)

[This corrects the article DOI: 10.1016/j.apsb.2020.02.014.].
Persistent COVID-19 in immunocompromised patients—Israeli society of infectious diseases consensus statement on diagnosis and management
Authors: Suzy E. Meijer, Yael Paran, Ana Belkin, Ronen Ben-Ami, Yasmin Maor, Lior Nesher, Khetam Hussein, Galia Rahav, Tal Brosh-Nissimov
Journal: Clinical Microbiology and Infection (2024)
Integrated single-cell transcriptome and T cell receptor profiling reveals defects of T cell exhaustion in pulmonary tuberculosis
Authors: Zilu Wen, Lin Wang, Hui Ma, Leilei Li, Laiyi Wan, Lei Shi, Hongwei Li, Hui Chen, Wentao Hao, Shu Song, Qinghua Xue, Yutong Wei, Feng Li, Jianqing Xu, Shulin Zhang, Ka-Wing Wong, Yanzheng Song
Journal: Journal of Infection (2024)

Tuberculosis-affected lungs with chronic inflammation harbor abundant immunosuppressive immune cells but the nature of such inflammation is unclear. Dysfunction in T cell exhaustion, while implicated in chronic inflammatory diseases, remains unexplored in tuberculosis. Given that immunotherapy targeting exhaustion checkpoints exacerbates tuberculosis, we speculate that T cell exhaustion is dysfunctional in tuberculosis. Using integrated single-cell RNA sequencing and T cell receptor profiling we reported defects in exhaustion responses within inflamed tuberculosis-affected lungs. Tuberculosis lungs demonstrated significantly reduced levels of exhausted CD8+ T cells and exhibited diminished expression of exhaustion-related transcripts among clonally expanded CD4+ and CD8+ T cells. Additionally, clonal expansion of CD4+ and CD8+ T cells bearing T cell receptors specific for CMV was observed. Expanded CD8+ T cells expressed the cytolytic marker GZMK. Hence, inflamed tuberculosis-affected lungs displayed dysfunction in T cell exhaustion. Our findings likely hold implications for understanding the reactivation of tuberculosis observed in patients undergoing immunotherapy targeting the exhaustion checkpoint.
Early life exposure to pollens and increased risks of childhood asthma: a prospective cohort study in Ontario children
Authors: Cristina Stanescu, Robert Talarico, Scott Weichenthal, Paul J. Villeneuve, Audrey Smargiassi, David M. Stieb, Teresa To, Christopher Hebbern, Eric Crighton, Éric Lavigne
Journal: European Respiratory Journal (2024)

<h3>Shareable abstract</h3> <b>Increased exposure to tree canopy around the place of residence at birth prevented the risk of childhood asthma development, but this protective effect can be reduced when exposure to weed and tree pollen increases</b> https://bit.ly/3Tboabo
Electroceuticals: emerging applications beyond the nervous system and excitable tissues
Authors: Swarnalatha Balasubramanian, David A. Weston, Michael Levin, Devon Charles Cardoso Davidian
Journal: Trends in Pharmacological Sciences (2024)

Electroceuticals have evolved beyond devices manipulating neuronal signaling for symptomatic treatment, becoming more precise and disease modulating and expanding beyond the nervous system. These advancements promise transformative applications in arthritis, cancer treatment, tissue regeneration, and more. Here, we discuss these recent advances and offer insights for future research.
Early postnatal high-dose fat-soluble enteral vitamin A supplementation for moderate or severe bronchopulmonary dysplasia or death in extremely low birthweight infants (NeoVitaA): a multicentre, randomised, parallel-group, double-blind, placebo-controlled, investigator-initiated phase 3 trial
Authors: Sascha Meyer, Johannes Bay, Axel R Franz, Harald Ehrhardt, Lars Klein, Jutta Petzinger, Christoph Binder, Susanne Kirschenhofer, Anja Stein, Britta Hüning, Axel Heep, Eva Cloppenburg, Julia Muyimbwa, Torsten Ott, Julia Sandkötter, Norbert Teig, Susanne Wiegand, Michael Schroth, Andrea Kick, Donald Wurm, Corinna Gebauer, Knud Linnemann, Jochen Kittel, Christian Wieg, Ursula Kiechl-Kohlendorfer, Susanne Schmidt, Ralf Böttger, Wolfgang Thomas, Francisco Brevis Nunez, Antje Stockmann, Thomas Kriebel, Andreas Müller, Daniel Klotz, Patrick Morhart, Donatus Nohr, Hans Konrad Biesalski, Eleni Z Giannopoulou, Susanne Hilt, Martin Poryo, Stefan Wagenpfeil, Nadja Haiden, Christian Ruckes, Anne Ehrlich, Ludwig Gortner, Rahel Schuler, Birgit Kampschulte, Annesuse Schmidt, Svilen Atanasov, Mark Dzietko, Sebastian Prager, Ioana Bialas, Petra Kramps, Sarah Beckmann, Jürgen Seidenberg, Katja Majosthusmann, Jenny Potratz, Alijda van den Heuvel, Maria Tekaat, Susanne Dettmers, Marie-Therese Unterweger, Heike Nowak, Jens Möller, Ulrich Thome, Jörg Arand, Beate Luger, Christian A Maiwald, Martin Heideking, Matthias Heckmann, Annette Keller-Wacherbauer, Holger Michel, Tanja Karen, Anna Schmid, Yasmin Pellkofer, Elke Griesmaier, Orsolya Genzel-Boroviczeny, Raquel Mata Fernandez, Stefan Avenarius, Andrea Czoske, Christoph Block, Simone Schwarz, Andreas Jenke, Tamara Grass, Martin Kuntz, Fabian Fahlbusch, Johannes Pöschl, Jule Metzger, Sebastian Ronellenfitsch, Thomas Schaible, Julia Reinhard, Sonja Trepels-Kottek, Jacqueline Bauer, Egbert Herting, Wolfram Henn, Annette Laupert, Rebecca Jathe
Journal: The Lancet Respiratory Medicine (2024)
Staging 2.0: refining transdiagnostic clinical staging frameworks to enhance reliability and utility for youth mental health
Authors: Jan Scott, Frank Iorfino, William Capon, Jacob Crouse, Barnaby Nelson, Andrew M Chanen, Dominic Dwyer, Philippe Conus, Andreas Bechdolf, Aswin Ratheesh, Andrea Raballo, Alison Yung, Michael Berk, Sarah McKenna, Samuel Hockey, Alexis Hutcheon, Elizabeth Scott, Pat McGorry, Jai Shah, Ian B Hickie
Journal: The Lancet Psychiatry (2024)
A low FODMAP diet plus traditional dietary advice versus a low-carbohydrate diet versus pharmacological treatment in irritable bowel syndrome (CARIBS): a single-centre, single-blind, randomised controlled trial
Authors: Sanna Nybacka, Hans Törnblom, Axel Josefsson, Johann P Hreinsson, Lena Böhn, Åsa Frändemark, Cecilia Weznaver, Stine Störsrud, Magnus Simrén
Journal: The Lancet. Gastroenterology & hepatology (2024)
Helping young people thrive in China: policy and culture
Authors: None The Lancet
Journal: The Lancet (2024)

China has made huge gains in child and adolescent health over the past 70 years. A focus on women's reproductive, maternal, newborn, child, and adolescent health has helped to drive down the mortality rate in those aged 5–19 years from 366·0 deaths per 100 000 during 1953–64 to 27·2 cases per 100 000 in 2016. Millions have been lifted out of poverty. However, as China has undergone socioeconomic and demographic changes, child and adolescent health has transitioned from an issue of surviving to one of thriving: most Chinese children do not have to worry about making it to their fifth birthday, but rather how to live fulfilling and healthy lives.
Swollen eyelids caused by polyvinylpyrrolidone histiocytosis with intravenous methylphenidate
Authors: Matias Wilenius, Juha Jernman, Aki Hietaharju, Tapani Salonen, Tiina Helasjoki, Ilkka Martikainen, Pasi Ilari Nevalainen
Journal: The Lancet (2024)
Medical articles should include a plain language summary
Authors: Mohamed L Seghier
Journal: The Lancet (2024)

In this era of personalised medicine, patients are expected to be actively involved in making care decisions that are best for them. Accurate and accessible medical information is key to successful patient-centred care, which can be supported by the availability of easy-to-understand summaries of published articles in medical journals. Obtaining relevant risk and benefit information on treatment alternatives ensures optimal health outcomes. In addition to information shared by physicians, patients and their relatives also rely on information gathered from the internet,1Daraz L Morrow AS Ponce OJ et al.Can patients trust online health information? A meta-narrative systematic review addressing the quality of health information on the internet.J Gen Intern Med. 2019; 34: 1884-1891Crossref PubMed Scopus (139) Google Scholar including published articles in scientific journals. However, scientific literature is challenging to those who are not experts. Consequently, clinically useful research, most often funded by public money, is not making its way to the general public. It is not unusual to hear the frustration of patients and their relatives after trying to look for reliable information that they can trust about a specific medical condition or a new treatment from research publications. This situation is not helped by digests conveyed by the media that are not always free of bias and misinterpretations.2Wang MTM Grey A Bolland MJ Conflicts of interest and expertise of independent commenters in news stories about medical research.CMAJ. 2017; 189: E553-E559Crossref Scopus (15) Google Scholar In this context, it is important that the crucial task of explaining medical research to the public should be undertaken by the original authors. We invite medical journals to include, for all or selected articles, a summary that uses everyday language so that the non-expert can appreciate the significance of the published work and its potential effects. Many funding bodies already require researchers to provide a lay summary of their research proposals, such as the Clinical Trial Regulation of the European Union, which requires plain language summaries of clinical trials to improve transparency.3Penlington M Silverman H Vasudevan A Pavithran P Plain language summaries of clinical trial results: a preliminary study to assess availability of easy-to-understand summaries and approaches to improving public engagement.Pharmaceut Med. 2020; 34: 401-406Google Scholar It is time to bring this requirement to medical journals. I declare no competing interests.
Offline: America's reckoning
Authors: Richard Horton
Journal: The Lancet (2024)

Donald J Trump, the 45th President of the USA, presided over an era that now seems strangely distant. It is hard to recall his chaos, his lies, his improprieties. It is even harder to imagine that the American people are seriously considering him for a second term. But what is more surprising still is the collective failure of the US Government, and the lack of insistent demand by American citizens, to learn the lessons of the Trump Presidency—and the management of the COVID-19 pandemic in particular.
Matching actions to needs: shifting policy responses to the changing health needs of Chinese children and adolescents
Authors: Tian-Jiao Chen, Bin Dong, Yanhui Dong, Jing Li, Yinghua Ma, Dongshan Liu, Yuhui Zhang, Yi Xing, Yi Zheng, Xiaomin Luo, Fangbiao Tao, Yanqing Ding, Peijin Hu, Zhiyong Zou, Bailin Pan, Ping Tang, Dongmei Luo, Yunfei Liu, Luo Li, Geffrey Nan Li, Xiaobo Tian, Xiaona Huang, Yi Song, Jun Ma, Susan M Sawyer
Journal: The Lancet (2024)
Heparan sulfates and heparan sulfate proteoglycans in hematopoiesis
Authors: Richard T. Piszczatowski, Hannes E. Bülow, Ulrich Steidl
Journal: Blood (2024)

From signaling mediators in stem cells to markers of differentiation and lineage commitment to facilitators for the entry of viruses, such as HIV-1, cell surface heparan sulfate (HS) glycans with distinct modification patterns play important roles in hematopoietic biology. In this review, we provide an overview of the importance of HS and the proteoglycans (HSPGs) to which they are attached within the major cellular subtypes of the hematopoietic system. We summarize the roles of HSPGs, HS, and HS modifications within each main hematopoietic cell lineage of both myeloid and lymphoid arms. Lastly, we discuss the biological advances in the detection of HS modifications and their potential to further discriminate cell types within hematopoietic tissue.
Effect of Isocaloric, Time-Restricted Eating on Body Weight in Adults With Obesity
Authors: Nisa M. Maruthur, Scott J. Pilla, Karen White, Beiwen Wu, May Thu Thu Maw, Daisy Duan, Ruth-Alma Turkson-Ocran, Di Zhao, Jeanne Charleston, Courtney M. Peterson, Ryan J. Dougherty, Jennifer A. Schrack, Lawrence J. Appel, Eliseo Guallar, Jeanne M. Clark
Journal: Annals of Internal Medicine (2024)

Time-restricted eating (TRE) lowers body weight in many studies. Whether TRE induces weight loss independent of reductions in calorie intake, as seen in rodent studies, is unknown.
Melatonin: a ferroptosis inhibitor with potential therapeutic efficacy for the post-COVID-19 trajectory of accelerated brain aging and neurodegeneration
Authors: Asmaa Yehia, Osama A. Abulseoud
Journal: Molecular Neurodegeneration (2024)

Abstract The unprecedented pandemic of COVID-19 swept millions of lives in a short period, yet its menace continues among its survivors in the form of post-COVID syndrome. An exponentially growing number of COVID-19 survivors suffer from cognitive impairment, with compelling evidence of a trajectory of accelerated aging and neurodegeneration. The novel and enigmatic nature of this yet-to-unfold pathology demands extensive research seeking answers for both the molecular underpinnings and potential therapeutic targets. Ferroptosis, an iron-dependent cell death, is a strongly proposed underlying mechanism in post-COVID-19 aging and neurodegeneration discourse. COVID-19 incites neuroinflammation, iron dysregulation, reactive oxygen species (ROS) accumulation, antioxidant system repression, renin-angiotensin system (RAS) disruption, and clock gene alteration. These events pave the way for ferroptosis, which shows its signature in COVID-19, premature aging, and neurodegenerative disorders. In the search for a treatment, melatonin shines as a promising ferroptosis inhibitor with its repeatedly reported safety and tolerability. According to various studies, melatonin has proven efficacy in attenuating the severity of certain COVID-19 manifestations, validating its reputation as an anti-viral compound. Melatonin has well-documented anti-aging properties and combating neurodegenerative-related pathologies. Melatonin can block the leading events of ferroptosis since it is an efficient anti-inflammatory, iron chelator, antioxidant, angiotensin II antagonist, and clock gene regulator. Therefore, we propose ferroptosis as the culprit behind the post-COVID-19 trajectory of aging and neurodegeneration and melatonin, a well-fitting ferroptosis inhibitor, as a potential treatment.
Newer Pharmacologic Treatments in Adults With Type 2 Diabetes: A Clinical Guideline From the American College of Physicians
Authors: Amir Qaseem, Adam J. Obley, Tatyana Shamliyan, Lauri A. Hicks, Curtis S. Harrod, Carolyn J. Crandall, Ethan M. Balk, Thomas G. Cooney, J. Thomas Cross, Nick Fitterman, Jennifer S. Lin, Michael Maroto, Matthew C. Miller, Paul Shekelle, Jeffrey A. Tice, Janice E. Tufte, Itziar Etxeandia-Ikobaltzeta, Jennifer Yost, Amir Qaseem, Adam J. Obley, Tatyana Shamliyan, Lauri A. Hicks, Curtis S. Harrod, Carolyn J. Crandall, Timothy J. Wilt, Douglas K. Owens, Kate Carroll, Ethan M. Balk, Thomas G. Cooney, J. Thomas Cross, Nick Fitterman, Jennifer S. Lin, Michael Maroto, Matthew C. Miller, Paul Shekelle, Jeffrey A. Tice, Janice E. Tufte, Itziar Etxeandia-Ikobaltzeta, Jennifer Yost
Journal: Annals of Internal Medicine (2024)

The American College of Physicians (ACP) developed this clinical guideline to update recommendations on newer pharmacologic treatments of type 2 diabetes. This clinical guideline is based on the best available evidence for effectiveness, comparative benefits and harms, consideration of patients' values and preferences, and costs.
Newer Pharmacologic Treatments in Adults With Type 2 Diabetes: A Systematic Review and Network Meta-analysis for the American College of Physicians
Authors: Tyler Drake, Adrienne Landsteiner, Lisa Langsetmo, Roderick MacDonald, Maylen Anthony, Caleb Kalinowski, Kristen Ullman, Charles J. Billington, Anjum Kaka, Shahnaz Sultan, Timothy J. Wilt
Journal: Annals of Internal Medicine (2024)

Newer diabetes medications may have beneficial effects on mortality, cardiovascular outcomes, and renal outcomes.
Cost-Effectiveness of Newer Pharmacologic Treatments in Adults With Type 2 Diabetes: A Systematic Review of Cost-Effectiveness Studies for the American College of Physicians
Authors: John T. Schousboe, Adrienne Landsteiner, Tyler Drake, Shahnaz Sultan, Lisa Langsetmo, Anjum Kaka, Maylen Anthony, Charles J. Billington, Caleb Kalinowski, Kristen Ullman, Timothy J. Wilt
Journal: Annals of Internal Medicine (2024)

In the United States, costs of antidiabetes medications exceed $327 billion.
Visual Guideline - Newer Pharmacologic Treatments in Adults With Type 2 Diabetes: A Visual Clinical Guideline From the American College of Physicians
Journal: Annals of Internal Medicine (2024)

The purpose of this visual clinical guideline is to provide a visual summary of ACP's clinical guideline, "Newer Pharmacologic Treatments in Adults With Type 2 Diabetes." In addition, this visual clinical guideline features an interactive data visualization of findings associated with ACP's clinical recommendations for this topic.
Author Correction: New genetic signals for lung function highlight pathways and chronic obstructive pulmonary disease associations across multiple ancestries
Authors: Nick Shrine, Anna L. Guyatt, A. Mesut Erzurumluoglu, Victoria E. Jackson, Brian D. Hobbs, Carl A. Melbourne, Chiara Batini, Katherine A. Fawcett, Kijoung Song, Phuwanat Sakornsakolpat, Xingnan Li, Ruth Boxall, Nicola F. Reeve, Ma’en Obeidat, Jing Hua Zhao, Matthias Wielscher, Stefan Weiss, Katherine A. Kentistou, James P. Cook, Benjamin B. Sun, Jian Zhou, Jennie Hui, Stefan Karrasch, Medea Imboden, Sarah E. Harris, Jonathan Marten, Stefan Enroth, Shona M. Kerr, Ida Surakka, Veronique Vitart, Terho Lehtimäki, Richard J. Allen, Per S. Bakke, Terri H. Beaty, Eugene R. Bleecker, Yohan Bossé, Corry-Anke Brandsma, Zhengming Chen, James D. Crapo, John Danesh, Dawn L. DeMeo, Frank Dudbridge, Ralf Ewert, Christian Gieger, Amund Gulsvik, Anna L. Hansell, Ke Hao, Joshua D. Hoffman, John E. Hokanson, Georg Homuth, Peter K. Joshi, Philippe Joubert, Claudia Langenberg, Xuan Li, Liming Li, Kuang Lin, Lars Lind, Nicholas Locantore, Jian’an Luan, Anubha Mahajan, Joseph C. Maranville, Alison Murray, David C. Nickle, Richard Packer, Margaret M. Parker, Megan L. Paynton, David J. Porteous, Dmitry Prokopenko, Dandi Qiao, Rajesh Rawal, Heiko Runz, Ian Sayers, Don D. Sin, Blair H. Smith, María Soler Artigas, David Sparrow, Ruth Tal-Singer, Paul R. H. J. Timmers, Maarten Van den Berge, John C. Whittaker, Prescott G. Woodruff, Laura M. Yerges-Armstrong, Olga G. Troyanskaya, Olli T. Raitakari, Mika Kähönen, Ozren Polašek, Ulf Gyllensten, Igor Rudan, Ian J. Deary, Nicole M. Probst-Hensch, Holger Schulz, Alan L. James, James F. Wilson, Beate Stubbe, Eleftheria Zeggini, Marjo-Riitta Jarvelin, Nick Wareham, Edwin K. Silverman, Caroline Hayward, Andrew P. Morris, Adam S. Butterworth, Robert A. Scott, Robin G. Walters, Deborah A. Meyers, Michael H. Cho, David P. Strachan, Ian P. Hall, Martin D. Tobin, Louise V. Wain
Journal: Nature Genetics (2024)
Astrocyte-mediated regulation of BLAWFS1 neurons alleviates risk-assessment deficits in DISC1-N mice
Authors: Xinyi Zhou, Qian Xiao, Yaohui Liu, Shuai Chen, Xirong Xu, Zhigang Zhang, Yuchuan Hong, Jie Shao, Yuewen Chen, Yu Chen, Liping Wang, Fan Yang, Jie Tu
Journal: Neuron (2024)